LYELL IMMUNOPHARMA INC (LYEL) Stock Cash Flow
NASDAQ:LYEL • US55083R2031
Current stock price
19.12 USD
-1.65 (-7.94%)
At close:
19.12 USD
0 (0%)
After Hours:
| 2025 (2025-12-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -274.45M | -342.99M | -234.63M | -183.12M | -250.22M | |||
| Depreciation Amortization | 11.54M | 19.63M | 20.25M | 18.02M | 13.62M | |||
| Change In Working Capital | -9.89M | -3.12M | 3.42M | -82.02M | 4.02M | |||
| Other non cash items | 122.78M | 164.09M | 47.27M | 77.56M | 106.33M | |||
| OPERATING CASH FLOW | -150.02M | -162.39M | -163.69M | -169.56M | -126.25M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -41.98M | -31.81M | -2.69M | -24.28M | -65.50M | |||
| Other Investing Activity | 96.07M | 154.23M | 186.73M | 12.74M | -56.07M | |||
| INVESTING CASH FLOW | 54.10M | 122.42M | 184.05M | -11.54M | -121.57M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Stock Issued/Repurchased | 50.41M | 1.40M | 2.20M | 11.10M | 401.24M | |||
| Other Financing Activity | -1.00K | -76.00K | -457.00K | -460.00K | N/A | |||
| FINANCING CASH FLOW | 50.41M | 1.33M | 1.74M | 10.64M | 401.24M | |||
| CHANGE IN CASH | -45.52M | -38.64M | 22.10M | -170.46M | 153.42M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -150.02M | -162.39M | -163.69M | -169.56M | -126.25M | |||
| Capital Expenditure | -41.98M | -31.81M | -2.69M | -24.28M | -65.50M | |||
| FREE CASH FLOW | -192.00M | -194.20M | -166.38M | -193.84M | -191.75M | |||
All data in USD